VEENA CHHEDA: Open Payments
NPI 1578622437 · HAMMONTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 11 payments from 5 companies in 2025. Trend: 2023 $1,035 · 2024 $1,276 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $160 |
| Alkermes, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: INVEGA, CAPLYTA, ARISTADA, FANAPT, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
